Literature DB >> 22306084

Functional melanocortin-2 receptors are expressed by mouse aorta-derived mesenchymal progenitor cells.

Jodi F Evans1, Anne Fernando, Louis Ragolia.   

Abstract

A local melanocortin system is active during tissue injury and inflammation. Thus far this system has been described as autocrine in nature where local production of pro-opiomelanocortin (POMC) peptides by leukocytes feeds back on melanocortin receptor (MC-R) expressing immune cells to quell inflammatory cytokine production. Here we present evidence that POMC peptides may generate extracellular matrix (ECM) changes by inducing matrix production by cells of the mesenchymal lineage through activation of the MC2-R. Using immunoblot, we determined that mouse aorta-derived mesenchymal progenitor cells express both MC2-R and MC3-R. These progenitors respond to treatment with ACTH by increasing collagen matrix synthesis as assessed by picrosirius red stain and (3)H-proline incorporation. ACTH also induces transient increases in intracellular calcium ([Ca(2+)](i)) as assessed using the fluorescent Ca(2+) indicator, fura-2. The ACTH-induced changes in [Ca(2+)](i) are consistent with MC2-R signaling and consist of both an intracellular release and an extracellular influx of Ca(2+). Both mouse aortic mesenchymal progenitors and mouse macrophage cells express POMC and the prohormone convertase 1/3 (PC1/3) indicating they have the potential to contribute to the local production of POMC peptides. These data demonstrate functional MC2-R expression in mouse aorta-derived mesenchymal progenitors and implicate both macrophage and mesenchymal cells as relevant sources of local POMC peptides. Copyright Â
© 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306084      PMCID: PMC3485690          DOI: 10.1016/j.mce.2012.01.019

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  49 in total

Review 1.  G protein pathways.

Authors:  Susana R Neves; Prahlad T Ram; Ravi Iyengar
Journal:  Science       Date:  2002-05-31       Impact factor: 47.728

Review 2.  Analytical and clinical aspects of adrenocorticotrophin determination.

Authors:  J A Talbot; J W Kane; A White
Journal:  Ann Clin Biochem       Date:  2003-09       Impact factor: 2.057

Review 3.  Structure, function and regulation of the melanocortin receptors.

Authors:  Yingkui Yang
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

4.  Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca(2+)](I).

Authors:  M J Hoogduijn; S McGurk; N P M Smit; P H Nibbering; J Ancans; A van der Laarse; A J Thody
Journal:  Biochem Biophys Res Commun       Date:  2002-01-18       Impact factor: 3.575

Review 5.  The role of melanocortins in adipocyte function.

Authors:  B A Boston
Journal:  Ann N Y Acad Sci       Date:  1999-10-20       Impact factor: 5.691

6.  ACTH enhances chondrogenesis in multipotential progenitor cells and matrix production in chondrocytes.

Authors:  Jodi F Evans; Qing-Tian Niu; J Atilio Canas; Chwan-L Shen; John F Aloia; James K Yeh
Journal:  Bone       Date:  2004-07       Impact factor: 4.398

7.  Agouti expression in human adipose tissue: functional consequences and increased expression in type 2 diabetes.

Authors:  Steven R Smith; Barbara Gawronska-Kozak; Lenka Janderová; Taylor Nguyen; Angela Murrell; Jacqueline M Stephens; Randall L Mynatt
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

8.  Prohormone convertase 1 (PC1) processing and sorting: effect of PC1 propeptide and proSAAS.

Authors:  Sang-Nam Lee; Emmanuel Prodhomme; Iris Lindberg
Journal:  J Endocrinol       Date:  2004-08       Impact factor: 4.286

Review 9.  Mechanism of action of ACTH: beyond cAMP.

Authors:  Nicole Gallo-Payet; Marcel D Payet
Journal:  Microsc Res Tech       Date:  2003-06-15       Impact factor: 2.769

10.  A peroxisome proliferator-response element in the murine mc2-r promoter regulates its transcriptional activation during differentiation of 3T3-L1 adipocytes.

Authors:  Luke A Noon; Adrian J L Clark; Peter J King
Journal:  J Biol Chem       Date:  2004-03-17       Impact factor: 5.157

View more
  6 in total

1.  Systemic and local ACTH produced during inflammatory states promotes osteochondrogenic mesenchymal cell differentiation contributing to the pathologic progression of calcified atherosclerosis.

Authors:  Jodi F Evans; Louis Ragolia
Journal:  Med Hypotheses       Date:  2012-09-29       Impact factor: 1.538

2.  ACTH promotes chondrogenic nodule formation and induces transient elevations in intracellular calcium in rat bone marrow cell cultures via MC2-R signaling.

Authors:  Jodi F Evans; Sylvana Rodriguez; Louis Ragolia
Journal:  Cell Tissue Res       Date:  2013-01-29       Impact factor: 5.249

3.  Development of autoimmune hair loss disease alopecia areata is associated with cardiac dysfunction in C3H/HeJ mice.

Authors:  Eddy Wang; Katy Chong; Mei Yu; Noushin Akhoundsadegh; David J Granville; Jerry Shapiro; Kevin J McElwee
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

4.  Mouse aorta-derived mesenchymal progenitor cells contribute to and enhance the immune response of macrophage cells under inflammatory conditions.

Authors:  Jodi F Evans; Veronica Salvador; Sheela George; Cristina Trevino-Gutierrez; Catherine Nunez
Journal:  Stem Cell Res Ther       Date:  2015-04-14       Impact factor: 6.832

5.  Mouse Mesenchymal Progenitor Cells Expressing Adipogenic and Osteogenic Transcription Factors Suppress the Macrophage Inflammatory Response.

Authors:  Natalie Fernandez; Heather Renna; Lauren McHugh; Katie Mazalkova; William Crugnola; Jodi F Evans
Journal:  Stem Cells Int       Date:  2017-01-16       Impact factor: 5.443

Review 6.  Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism.

Authors:  Nada El Ghorayeb; Isabelle Bourdeau; André Lacroix
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-27       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.